Product NDC: | 27505-003 |
Proprietary Name: | Revonto |
Non Proprietary Name: | dantrolene sodium |
Active Ingredient(s): | 20 mg/60mL & nbsp; dantrolene sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 27505-003 |
Labeler Name: | US WorldMeds, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078378 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120604 |
Package NDC: | 27505-003-68 |
Package Description: | 6 VIAL, GLASS in 1 CARTON (27505-003-68) > 60 mL in 1 VIAL, GLASS |
NDC Code | 27505-003-68 |
Proprietary Name | Revonto |
Package Description | 6 VIAL, GLASS in 1 CARTON (27505-003-68) > 60 mL in 1 VIAL, GLASS |
Product NDC | 27505-003 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | dantrolene sodium |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120604 |
Marketing Category Name | ANDA |
Labeler Name | US WorldMeds, LLC |
Substance Name | DANTROLENE SODIUM |
Strength Number | 20 |
Strength Unit | mg/60mL |
Pharmaceutical Classes | Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC] |